Brian Lian - 05 Jan 2023 Form 4 Insider Report for SEELOS THERAPEUTICS, INC. (SEEL)

Role
Director
Signature
/s/ Michael Golembiewski, as attorney-in-fact for Brian Lian
Issuer symbol
SEEL
Transactions as of
05 Jan 2023
Transactions value $
$0
Form type
4
Filing time
05 Jan 2023, 18:18:19
Previous filing
04 Jan 2023
Next filing
03 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SEEL Stock Option (right to buy) Award $0 +50K $0.00 50K 05 Jan 2023 Common Stock 50K $0.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the shares subject to the option shall vest on February 5, 2023, and 1/12th of the shares subject to the option shall vest monthly thereafter.

Remarks:

Exhibit 24 - Power of Attorney